Listed in reverse chronological order: Caucuses, Coffee Shop Focus Groups, and Cholesterol The Statin Lottery: Number Needed to Treat Statistic Mevacor - STRIKE THREE! Yer Outta Here! Lilly, Sweden, Bribes and Conspiracy Theories Merck to Vioxx Plaintiffs: Settle or Else! What the US FDA Could Learn from China's FDA Another Award for Rozerem! This one...not so good. Statins and Heart Disease: Look Behind the Curtain Gardasil: Is the Risk of Being "One Less" Worth It? Lilly Cymbalta Marketers are NOT Practicing What Lilly Executives Preach! DTC Here to Stay; Pet Turtles Too! Risk-First DTC: A Tactic to Overcome Resistance An Innovative System for Communicating Drug Risks to Patients FDA Considers Color Code for Food Labels, But Not for Drug Labels FDA at a Mall Near You: The Manchurian Connection FDA's Chang and Eng: Benefit vs. Risk Can an In-home Electronic Pillbox Solve Our Medication Error Problem? FDA: Zimulti Non-Acomplia! Avandia Hearing Soap Opera: Ethics, Demagogy, Sensationalism, and Threats by GSK Avandia Hearing Begins with Slurs Against NEJM and Majority Members Pharma Hires Charlatans for Research & Marketing! Avandia: Enough Blame to Go Around GSK May "Step Into the [DTC] Void" to Defend Avandia Temple vs. Nissen: Blood Rematch Myth #1: High U.S. Drug Prices Guarantee Us First Shot at New Drugs Imagine There's No DTC. I Wonder If You Can. DUI: Dispensing Under the Influence This is Your Inner Ear on Drugs! Botox Banality Not a Boon for TV Sitcoms Celebrex Ad: Let's Dive Deeper The New Celebrex TV Ad: What Did You Learn? Acomplia Not for the Gun Totting Bikini Crowd von Eschenbach & Gonzales: Two Birds in the Same Bush Drug Safety - A Mere Asterisk to the FDA Alli Oops! I Just Pooped Myself! Gardasil: To Be Mandatory or Not To Be Mandatory -- That is the Question Pfizer PhD Phobia PDUFA Payola! Betting the Pharm torcetrapib: "$800 Million" Failure but Kindler Safe Pfizer's torcetrapib: Who Knew What, When? Off-Label Confusion Lame-Duck Senate Roasts Eschenbach Turkey! Pay Per DTC Ad View Update What's In Store from Congress? Marketing 101: Newer is Better Print DTC, PhRMA Guidelines, and Balance Imprecise DTC Benefit Messages Apres IOM, le Deluge! IOM Report Calls for DTC Moratorium Health Literacy - Words Fail to Tell the Story Caduet, Smaduet! Add some wood to the fire! WLF: A No-Risk Ad is a Good Ad Accountability: Imported vs. Domestic PhRMA Intern Tackles Terrorists! Generics: Physicians Less Informed than Consumers! FDA Paralyzed: Who Will Protect Us? Drug Risks: Consumers Less Concerned than Docs FDA Gets a "C" from the Public Pfizer Imitating Art or Vice Versa? Celsius 3014: Ketek, Drug Safety, & Bioterrorism Spinning Bad News about FDA & Drug Safety FDA Coming to a Mall Near You? DTC without Risk Revisited Merck Misled FDA According to NJ Jury DTC without the Risk Marketing "Acceptable Risk" PhRMA's Terrorist Plot Labeling / TV DTC Revisited HELP WANTED: Director of Drug Safety Future of Drug Print Ads Terror Politics vs Drug Importation Proposal for a Drug Risk Advisory System FDA Drug Watch Site Guidelines "Bioshield" Boondoggle Drug Safety: A Matter of Trust! FDA Advisory Panels: Elephants in the Room Canada: Mad Cows Yes, Drugs No! Can Drug Ads Communicate Risk?